소프트 미스트 흡입기 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 8.3%의 연평균 복합 성장률(CAGR)로 42억 4,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 전 세계 오염 수준 증가, 노인 인구 증가, 천식 및 COPD 발병률 증가, 비침습적 약물 전달 방법의 채택 증가, 신흥 시장에서의 의료 인프라 확대 등에 기인합니다. 예측 기간 동안 주요 동향으로는 휴대가 간편하고 사용하기 쉬운 흡입기에 대한 수요 증가, 친환경적이고 지속 가능한 흡입기 설계에 대한 관심 증가, 흡입기와 디지털 헬스 솔루션의 통합 증가, 개인화된 환자 중심 치료로의 전환, 약물 전달 기술의 발전 등이 있습니다.
천식 유병률 증가는 향후 몇 년 동안 소프트 미스트 흡입기 시장의 성장을 가속할 것으로 예측됩니다. 천식은 기도의 염증과 협착을 일으켜 호흡 곤란을 유발하는 만성 호흡기 질환입니다. 천식 환자 증가는 주로 대기 오염에 대한 노출 증가로 인해 호흡기 상태를 악화시키고 시간이 지남에 따라 폐 기능에 손상을 입힐 수 있습니다. 소프트 미스트 흡입기는 천식 및 기타 만성 폐쇄성 폐질환 관리에 있어 미세하고 천천히 움직이는 미스트 형태의 약물을 폐에 직접 분사하여 약물의 침착을 개선하고 최소한의 노력으로 호흡기를 완화합니다. 예를 들어, 2023년 12월 호주 통계청은 2022년 호주에서 약 280만 명(인구의 10.8%)이 천식을 앓고 있다고 보고했습니다. 또한 천식 환자 3명 중 1명(33.9%)이 매일 천식약을 사용하고 있다고 보고했습니다. 결과적으로 천식과 만성폐쇄성폐질환(COPD)의 유병률 증가는 소프트미스트 흡입기 시장의 성장에 기여하고 있습니다.
소프트 미스트 흡입기(SMI) 시장의 주요 기업들은 시장에서의 입지를 강화하고 제품 접근성을 높이기 위해 전략적 파트너십에 집중하고 있습니다. 이들 기업은 연구 기관, 기술 기업, 지역 의료 서비스 제공업체와 협력하여 각자의 강점을 결합하여 혁신적이고 환자 중심의 흡입 요법을 제공하는 데 있어 경쟁 우위를 확보하고자 합니다. 예를 들어, 2024년 제네릭 및 맞춤형 흡입기 장치 설계 및 공급을 전문으로 하는 영국 기업 Merxin Ltd.는 독일 의료기기 제조업체인 OECHSLERhealth와 파트너십을 체결했습니다. 이 파트너십은 소프트 미스트 흡입기(SMI) 파워하우스(Powerhouse)의 출범으로 이어졌습니다. 이 구상은 의약품 개발자 시장 진입을 가속화하기 위한 것으로, OECHSLER Health와의 제휴를 통해 OECHSLER Health의 제조 및 조립 전문 지식과 메르신의 독자적인 SMI 설계를 결합하는 것을 포함합니다. 양사는 지적재산권 보호, 성능, 신뢰성, 신뢰성, 속도, 비용 효율성 측면에서 새로운 업계 표준을 세울 계획입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 소프트 미스트 흡입기 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 소프트 미스트 흡입기 시장 : 성장률 분석
- 세계의 소프트 미스트 흡입기 시장 실적 : 규모와 성장, 2019-2024
- 세계의 소프트 미스트 흡입기 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 소프트 미스트 흡입기 전체 시장(TAM)
제6장 시장 세분화
- 세계의 소프트 미스트 흡입기 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 휴대용 소프트 미스트 흡입기
- 고정형 소프트 미스트 흡입기
- 세계의 소프트 미스트 흡입기 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 천식
- 만성 폐쇄성 폐질환(COPD)
- 호흡기 질환
- 기타 용도
- 세계의 소프트 미스트 흡입기 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 및 진료소
- 가정치료 환경
- 기타 최종사용자
- 세계의 소프트 미스트 흡입기 시장 : 휴대용 소프트 미스트 흡입기 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 핸드헬드 재이용 가능 소프트 미스트 흡입기
- 일회용 소프트 미스트 흡입기
- 컴팩트 여행용 흡입기
- 소아용 휴대용 소프트 미스트 흡입기
- 세계의 소프트 미스트 흡입기 시장 : 고정형 소프트 미스트 흡입기 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 홈케어용 고정형 흡입기
- 병원 등급 소프트 미스트 흡입기
- 통합 네뷸라이저 시스템
- 장기 치료 장비
제7장 지역별/국가별 분석
- 세계의 소프트 미스트 흡입기 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 소프트 미스트 흡입기 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 소프트 미스트 흡입기 시장 : 경쟁 구도
- 소프트 미스트 흡입기 시장 : 기업 개요
- Merck & Co. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis International AG : 개요, 제품 및 서비스, 전략 및 재무 분석
- AstraZeneca plc : 개요, 제품 및 서비스, 전략 및 재무 분석
- GlaxoSmithKline plc : 개요, 제품 및 서비스, 전략 및 재무 분석
- Boehringer Ingelheim Pharma GmbH & Co. KG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Philips Respironics Inc.
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- 3M Healthcare
- Omron Healthcare Inc.
- AptarGroup Inc.
- Chiesi Farmaceutici S.p.A.
- Cipla Limited
- Hikma Pharmaceuticals plc
- Mundipharma International Limited
- Hovione Ltd.
- Vectura Group Limited
- MannKind Corporation
- H&T Presspart Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 소프트 미스트 흡입기 시장(2029년) : 새로운 기회를 제공하는 국가
- 소프트 미스트 흡입기 시장(2029년) : 새로운 기회를 제공하는 부문
- 소프트 미스트 흡입기 시장(2029년) : 성장 전략
제36장 부록
LSH
A soft mist inhaler (SMI) is an inhalation device that delivers medication as a slow-moving, long-lasting aerosol mist, generated without the use of propellants. This method allows for better lung deposition and easier inhalation, making it especially beneficial for patients with limited inspiratory capacity.
The main product types of soft mist inhalers include portable soft mist inhalers and stationary soft mist inhalers. Portable soft mist inhalers are designed for delivering medication in the form of a fine mist for treating respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). The various applications of soft mist inhalers include asthma, COPD, and other respiratory diseases. They are used by several end-users, including hospitals and clinics, home care settings, and others.
The soft mist inhalers market research report is one of a series of new reports from The Business Research Company that provides soft mist inhalers market statistics, including the soft mist inhalers industry global market size, regional shares, competitors with the soft mist inhalers market share, detailed soft mist inhalers market segments, market trends, and opportunities, and any further data you may need to thrive in the soft mist inhalers industry. This soft mist inhalers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The soft mist inhalers market size has grown strongly in recent years. It will grow from $2.84 billion in 2024 to $3.09 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing adoption of inhaler devices for asthma and COPD treatment, rising healthcare awareness, growing demand for advanced healthcare solutions, and increasing healthcare expenditure and access.
The soft mist inhalers market size is expected to see strong growth in the next few years. It will grow to $4.24 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth during the forecast period can be attributed to rising global pollution levels, a growing geriatric population, an increasing incidence of asthma and COPD, the rising adoption of non-invasive drug delivery methods, and expanding healthcare infrastructure in emerging markets. Key trends in the forecast period include growing demand for portable and easy-to-use inhalers, a focus on eco-friendly and sustainable inhaler designs, increasing integration of digital health solutions with inhalers, a shift toward personalized and patient-centric treatments, and advancements in drug delivery technology.
The growing prevalence of asthma is expected to drive the expansion of the soft mist inhalers market in the coming years. Asthma is a chronic respiratory disease that leads to inflammation and narrowing of the airways, making breathing difficult. The rise in asthma cases is mainly attributed to the increasing exposure to air pollution, which worsens respiratory conditions and damages lung function over time. Soft mist inhalers assist in managing asthma and other chronic obstructive pulmonary diseases by delivering a fine, slow-moving mist of medication directly to the lungs, improving drug deposition and providing respiratory relief with minimal effort in coordination. For example, in December 2023, the Australian Bureau of Statistics reported that in 2022, about 2.8 million people in Australia (10.8% of the population) had asthma. Additionally, one in three individuals with asthma (33.9%) reported using asthma medication daily. Consequently, the rising prevalence of asthma and chronic obstructive pulmonary disease (COPD) is contributing to the growth of the soft mist inhalers market.
Key players in the soft mist inhalers (SMIs) market are focusing on strategic partnerships to increase their market presence and improve product accessibility. These companies aim to combine their strengths to gain a competitive advantage in delivering innovative, patient-focused inhalation therapies by collaborating with research organizations, technology firms, and local healthcare providers. For instance, in 2024, Merxin Ltd., a UK-based company specializing in the design and supply of generic and customized inhaler devices, formed a partnership with OECHSLERhealth, a German manufacturer of medical devices. This collaboration led to the launch of the Soft Mist Inhalers (SMI) Powerhouse. This initiative aims to speed up market entry for drug developers and includes a partnership with OECHSLER Health to combine its manufacturing and assembly expertise with Merxin's proprietary SMI design. Together, they plan to set new industry standards in intellectual property protection, performance, reliability, speed, and cost-effectiveness.
In January 2024, Recipharm AB, a Sweden-based pharmaceutical company, joined forces with Medspray to expand the use of soft mist inhaler (SMI) technology beyond conventional respiratory treatments by developing soft mist nasal delivery devices for both single and combination drug products. This partnership aligns with Recipharm's strategy to innovate drug delivery solutions and diversify its offerings in advanced inhalation technologies. Medspray, based in the Netherlands, specializes in soft mist inhalers and spray delivery systems.
Major players in the soft mist inhalers market are Merck & Co., Novartis International AG, AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim Pharma GmbH & Co. KG, Philips Respironics Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., 3M Healthcare, Omron Healthcare Inc., AptarGroup Inc., Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals plc, Mundipharma International Limited, Hovione Ltd., Vectura Group Limited, MannKind Corporation, H&T Presspart Ltd., Sunovion Pharmaceuticals Inc., Merxin Ltd., Adherium Limited.
North America was the largest region in the soft mist inhalers market in 2024. The regions covered in soft mist inhalers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the soft mist inhalers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The soft mist inhalers market consists of sales of respimat inhalers, tiotropium, and ipratropium. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Soft Mist Inhalers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on soft mist inhalers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for soft mist inhalers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The soft mist inhalers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Portable Soft Mist Inhalers; Stationary Soft Mist Inhalers
- 2) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Respiratory Diseases; Other Applications
- 3) By End-User: Hospitals And Clinics; Home Care Settings; Other End-Users
- Subsegments:
- 1) By Portable Soft Mist Inhalers: Handheld Reusable Soft Mist Inhalers; Disposable Single-Use Soft Mist Inhalers; Compact Travel-Friendly Inhalers; Pediatric-Use Portable Soft Mist Inhalers
- 2) By Stationary Soft Mist Inhalers: Homecare-Use Stationary Inhalers; Hospital-Grade Soft Mist Inhalers; Integrated Nebulizer Systems; Long-Term Therapy Devices
- Companies Mentioned: Merck & Co.; Novartis International AG; AstraZeneca plc; GlaxoSmithKline plc; Boehringer Ingelheim Pharma GmbH & Co. KG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Soft Mist Inhalers Market Characteristics
3. Soft Mist Inhalers Market Trends And Strategies
4. Soft Mist Inhalers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Soft Mist Inhalers Growth Analysis And Strategic Analysis Framework
- 5.1. Global Soft Mist Inhalers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Soft Mist Inhalers Market Growth Rate Analysis
- 5.4. Global Soft Mist Inhalers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Soft Mist Inhalers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Soft Mist Inhalers Total Addressable Market (TAM)
6. Soft Mist Inhalers Market Segmentation
- 6.1. Global Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Portable Soft Mist Inhalers
- Stationary Soft Mist Inhalers
- 6.2. Global Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Respiratory Diseases
- Other Applications
- 6.3. Global Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Home Care Settings
- Other End-Users
- 6.4. Global Soft Mist Inhalers Market, Sub-Segmentation Of Portable Soft Mist Inhalers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Handheld Reusable Soft Mist Inhalers
- Disposable Single-Use Soft Mist Inhalers
- Compact Travel-Friendly Inhalers
- Pediatric-Use Portable Soft Mist Inhalers
- 6.5. Global Soft Mist Inhalers Market, Sub-Segmentation Of Stationary Soft Mist Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Homecare-Use Stationary Inhalers
- Hospital-Grade Soft Mist Inhalers
- Integrated Nebulizer Systems
- Long-Term Therapy Devices
7. Soft Mist Inhalers Market Regional And Country Analysis
- 7.1. Global Soft Mist Inhalers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Soft Mist Inhalers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Soft Mist Inhalers Market
- 8.1. Asia-Pacific Soft Mist Inhalers Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Soft Mist Inhalers Market
- 9.1. China Soft Mist Inhalers Market Overview
- 9.2. China Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Soft Mist Inhalers Market
- 10.1. India Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Soft Mist Inhalers Market
- 11.1. Japan Soft Mist Inhalers Market Overview
- 11.2. Japan Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Soft Mist Inhalers Market
- 12.1. Australia Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Soft Mist Inhalers Market
- 13.1. Indonesia Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Soft Mist Inhalers Market
- 14.1. South Korea Soft Mist Inhalers Market Overview
- 14.2. South Korea Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Soft Mist Inhalers Market
- 15.1. Western Europe Soft Mist Inhalers Market Overview
- 15.2. Western Europe Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Soft Mist Inhalers Market
- 16.1. UK Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Soft Mist Inhalers Market
- 17.1. Germany Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Soft Mist Inhalers Market
- 18.1. France Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Soft Mist Inhalers Market
- 19.1. Italy Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Soft Mist Inhalers Market
- 20.1. Spain Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Soft Mist Inhalers Market
- 21.1. Eastern Europe Soft Mist Inhalers Market Overview
- 21.2. Eastern Europe Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Soft Mist Inhalers Market
- 22.1. Russia Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Soft Mist Inhalers Market
- 23.1. North America Soft Mist Inhalers Market Overview
- 23.2. North America Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Soft Mist Inhalers Market
- 24.1. USA Soft Mist Inhalers Market Overview
- 24.2. USA Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Soft Mist Inhalers Market
- 25.1. Canada Soft Mist Inhalers Market Overview
- 25.2. Canada Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Soft Mist Inhalers Market
- 26.1. South America Soft Mist Inhalers Market Overview
- 26.2. South America Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Soft Mist Inhalers Market
- 27.1. Brazil Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Soft Mist Inhalers Market
- 28.1. Middle East Soft Mist Inhalers Market Overview
- 28.2. Middle East Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Soft Mist Inhalers Market
- 29.1. Africa Soft Mist Inhalers Market Overview
- 29.2. Africa Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Soft Mist Inhalers Market Competitive Landscape And Company Profiles
- 30.1. Soft Mist Inhalers Market Competitive Landscape
- 30.2. Soft Mist Inhalers Market Company Profiles
- 30.2.1. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Boehringer Ingelheim Pharma GmbH & Co. KG Overview, Products and Services, Strategy and Financial Analysis
31. Soft Mist Inhalers Market Other Major And Innovative Companies
- 31.1. Philips Respironics Inc.
- 31.2. Viatris Inc.
- 31.3. Teva Pharmaceutical Industries Ltd.
- 31.4. Mylan N.V.
- 31.5. 3M Healthcare
- 31.6. Omron Healthcare Inc.
- 31.7. AptarGroup Inc.
- 31.8. Chiesi Farmaceutici S.p.A.
- 31.9. Cipla Limited
- 31.10. Hikma Pharmaceuticals plc
- 31.11. Mundipharma International Limited
- 31.12. Hovione Ltd.
- 31.13. Vectura Group Limited
- 31.14. MannKind Corporation
- 31.15. H&T Presspart Ltd.
32. Global Soft Mist Inhalers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Soft Mist Inhalers Market
34. Recent Developments In The Soft Mist Inhalers Market
35. Soft Mist Inhalers Market High Potential Countries, Segments and Strategies
- 35.1 Soft Mist Inhalers Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Soft Mist Inhalers Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Soft Mist Inhalers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
